Panniculitis in Dermatomyositis
University Hospital, Strasbourg, France
20 participants
Oct 20, 2025
OBSERVATIONAL
Conditions
Summary
Adipose tissue involvement is rare in dermatomyositis. The occurrence of partial or diffuse lipodystrophy is a rare but well-characterized manifestation, particularly in juvenile forms of dermatomyositis. Panniculitis, on the other hand, is exceptional and rarely described in the literature, mostly in the form of clinical cases. Panniculitis in dermatomyositis is exceptional. There are no validated diagnostic criteria or treatment recommendations. Treatment is based, by analogy, on the therapeutic strategy for lupus panniculitis and involves synthetic antimalarials combined with steroids and/or immunosuppressants. The aim of this study is to describe panniculitis in dermatomyositis in order to determine whether there are clinical or histological characteristics that distinguish it from other causes of panniculitis, particularly panniculitis associated with lupus erythematosus.
Eligibility
Inclusion Criteria3
- Subject aged 1 year and older
- With a confirmed diagnosis of dermatomyositis
- With a confirmed diagnosis of panniculitis
Exclusion Criteria1
- Panniculitis for which another cause has been established, particularly infectious and metabolic panniculitis
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07345949